StockData
ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Electra Therapeutics, Inc.

$8.61−0.14 (-1.60%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Electra Therapeutics, Inc. revenue by segment

No segment breakdown reported

Electra Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.